The 44th Annual Chemotherapy Foundation Symposium (CFS) will be held from November 11–13, 2026, at the New York Hilton Midtown.

Chaired by a distinguished faculty including Dr. Benjamin P. Levy, Dr. John O. Mascarenhas, and Dr. Tiffany A. Traina, this premier three-day conference bridges the gap between basic science and clinical application for solid and hematologic malignancies. The 2026 program delivers a comprehensive overview of evidence-based, state-of-the-art cancer care, focusing on the seamless integration of targeted therapies, immunotherapies, and multimodal strategies into daily practice. Highlights include specialized sessions on emerging ADC technology, CAR-T cell therapy advancements for hematologic cancers, and personalized treatment sequencing for breast and lung malignancies to optimize patient outcomes.

Register now.